A "prime-pull" immunotherapy approach using a lentiviral vector and intratumoral TLR4 agonist redirects cytotoxic T cells

Detalles Bibliográficos
Autores principales: Albershardt, Tina C, Parsons, Andrea J, Flynn, Patrick, Berglund, Peter, ter Meulen, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292388/
http://dx.doi.org/10.1186/2051-1426-2-S3-P190
_version_ 1782352477207658496
author Albershardt, Tina C
Parsons, Andrea J
Flynn, Patrick
Berglund, Peter
ter Meulen, Jan
author_facet Albershardt, Tina C
Parsons, Andrea J
Flynn, Patrick
Berglund, Peter
ter Meulen, Jan
author_sort Albershardt, Tina C
collection PubMed
description
format Online
Article
Text
id pubmed-4292388
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42923882015-01-15 A "prime-pull" immunotherapy approach using a lentiviral vector and intratumoral TLR4 agonist redirects cytotoxic T cells Albershardt, Tina C Parsons, Andrea J Flynn, Patrick Berglund, Peter ter Meulen, Jan J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4292388/ http://dx.doi.org/10.1186/2051-1426-2-S3-P190 Text en Copyright © 2014 Albershardt et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Albershardt, Tina C
Parsons, Andrea J
Flynn, Patrick
Berglund, Peter
ter Meulen, Jan
A "prime-pull" immunotherapy approach using a lentiviral vector and intratumoral TLR4 agonist redirects cytotoxic T cells
title A "prime-pull" immunotherapy approach using a lentiviral vector and intratumoral TLR4 agonist redirects cytotoxic T cells
title_full A "prime-pull" immunotherapy approach using a lentiviral vector and intratumoral TLR4 agonist redirects cytotoxic T cells
title_fullStr A "prime-pull" immunotherapy approach using a lentiviral vector and intratumoral TLR4 agonist redirects cytotoxic T cells
title_full_unstemmed A "prime-pull" immunotherapy approach using a lentiviral vector and intratumoral TLR4 agonist redirects cytotoxic T cells
title_short A "prime-pull" immunotherapy approach using a lentiviral vector and intratumoral TLR4 agonist redirects cytotoxic T cells
title_sort "prime-pull" immunotherapy approach using a lentiviral vector and intratumoral tlr4 agonist redirects cytotoxic t cells
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292388/
http://dx.doi.org/10.1186/2051-1426-2-S3-P190
work_keys_str_mv AT albershardttinac aprimepullimmunotherapyapproachusingalentiviralvectorandintratumoraltlr4agonistredirectscytotoxictcells
AT parsonsandreaj aprimepullimmunotherapyapproachusingalentiviralvectorandintratumoraltlr4agonistredirectscytotoxictcells
AT flynnpatrick aprimepullimmunotherapyapproachusingalentiviralvectorandintratumoraltlr4agonistredirectscytotoxictcells
AT berglundpeter aprimepullimmunotherapyapproachusingalentiviralvectorandintratumoraltlr4agonistredirectscytotoxictcells
AT termeulenjan aprimepullimmunotherapyapproachusingalentiviralvectorandintratumoraltlr4agonistredirectscytotoxictcells
AT albershardttinac primepullimmunotherapyapproachusingalentiviralvectorandintratumoraltlr4agonistredirectscytotoxictcells
AT parsonsandreaj primepullimmunotherapyapproachusingalentiviralvectorandintratumoraltlr4agonistredirectscytotoxictcells
AT flynnpatrick primepullimmunotherapyapproachusingalentiviralvectorandintratumoraltlr4agonistredirectscytotoxictcells
AT berglundpeter primepullimmunotherapyapproachusingalentiviralvectorandintratumoraltlr4agonistredirectscytotoxictcells
AT termeulenjan primepullimmunotherapyapproachusingalentiviralvectorandintratumoraltlr4agonistredirectscytotoxictcells

Ejemplares similares